Kiniksa Pharmaceuticals International, plc (KNSA)
NASDAQ: KNSA · Real-Time Price · USD
56.74
-0.88 (-1.53%)
At close: May 5, 2026, 4:00 PM EDT
55.64
-1.10 (-1.94%)
After-hours: May 5, 2026, 7:27 PM EDT
KNSA Stock Forecast
Stock Price Forecast
The 7 analysts that cover KNSA stock have a consensus rating of "Strong Buy" and an average price target of $60.86, which forecasts a 7.26% increase in the stock price over the next year. The lowest target is $55 and the highest is $71.
Price Target: $60.86 (+7.26%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for KNSA stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 5 | 5 | 5 | 5 |
| Buy | 4 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 6 | 7 | 7 | 7 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $62 → $64 | Strong Buy | Maintains | $62 → $64 | +12.80% | Apr 29, 2026 |
| Citigroup | Citigroup | Strong Buy Maintains $50 → $60 | Strong Buy | Maintains | $50 → $60 | +5.75% | Apr 29, 2026 |
| Wedbush | Wedbush | Buy Maintains $58 → $59 | Buy | Maintains | $58 → $59 | +3.98% | Apr 29, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $53 → $57 | Buy | Maintains | $53 → $57 | +0.46% | Apr 29, 2026 |
| Jefferies | Jefferies | Strong Buy Maintains $58 → $71 | Strong Buy | Maintains | $58 → $71 | +25.13% | Apr 28, 2026 |
Financial Forecast
Revenue This Year
931.53M
from 677.56M
Increased by 37.48%
Revenue Next Year
1.10B
from 931.53M
Increased by 17.87%
EPS This Year
1.05
from 0.75
Increased by 39.63%
EPS Next Year
1.51
from 1.05
Increased by 43.83%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 966.0M | 1.2B | ||||||
| Avg | 931.5M | 1.1B | ||||||
| Low | 888.9M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 42.6% | 27.4% | ||||||
| Avg | 37.5% | 17.9% | ||||||
| Low | 31.2% | 9.7% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 1.20 | 1.90 | ||||||
| Avg | 1.05 | 1.51 | ||||||
| Low | 0.80 | 1.09 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 59.6% | 81.5% | ||||||
| Avg | 39.6% | 43.8% | ||||||
| Low | 7.1% | 3.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.